TY - JOUR
T1 - Quality of intensity modulated radiation therapy treatment plans using a 60Co magnetic resonance image guidance radiation therapy system
AU - Wooten, H. Omar
AU - Green, Olga
AU - Yang, Min
AU - Dewees, Todd
AU - Kashani, Rojano
AU - Olsen, Jeff
AU - Michalski, Jeff
AU - Yang, Deshan
AU - Tanderup, Kari
AU - Hu, Yanle
AU - Li, H. Harold
AU - Mutic, Sasa
N1 - Publisher Copyright:
© 2015 Elsevier Inc. All rights reserved.
PY - 2015/7/15
Y1 - 2015/7/15
N2 - Purpose This work describes a commercial treatment planning system, its technical features, and its capabilities for creating 60Co intensity modulated radiation therapy (IMRT) treatment plans for a magnetic resonance image guidance radiation therapy (MR-IGRT) system. Methods and Materials The ViewRay treatment planning system (Oakwood Village, OH) was used to create 60Co IMRT treatment plans for 33 cancer patients with disease in the abdominal, pelvic, thorax, and head and neck regions using physician-specified patient-specific target coverage and organ at risk (OAR) objectives. Backup plans using a third-party linear accelerator (linac)-based planning system were also created. Plans were evaluated by attending physicians and approved for treatment. The 60Co and linac plans were compared by evaluating conformity numbers (CN) with 100% and 95% of prescription reference doses and heterogeneity indices (HI) for planning target volumes (PTVs) and maximum, mean, and dose-volume histogram (DVH) values for OARs. Results All 60Co IMRT plans achieved PTV coverage and OAR sparing that were similar to linac plans. PTV conformity for 60Co was within <1% and 3% of linac plans for 100% and 95% prescription reference isodoses, respectively, and heterogeneity was on average 4% greater. Comparisons of OAR mean dose showed generally better sparing with linac plans in the low-dose range <20 Gy, but comparable sparing for organs with mean doses >20 Gy. The mean doses for all 60Co plan OARs were within clinical tolerances. Conclusions A commercial 60Co MR-IGRT device can produce highly conformal IMRT treatment plans similar in quality to linac IMRT for a variety of disease sites. Additional work is in progress to evaluate the clinical benefit of other novel features of this MR-IGRT system.
AB - Purpose This work describes a commercial treatment planning system, its technical features, and its capabilities for creating 60Co intensity modulated radiation therapy (IMRT) treatment plans for a magnetic resonance image guidance radiation therapy (MR-IGRT) system. Methods and Materials The ViewRay treatment planning system (Oakwood Village, OH) was used to create 60Co IMRT treatment plans for 33 cancer patients with disease in the abdominal, pelvic, thorax, and head and neck regions using physician-specified patient-specific target coverage and organ at risk (OAR) objectives. Backup plans using a third-party linear accelerator (linac)-based planning system were also created. Plans were evaluated by attending physicians and approved for treatment. The 60Co and linac plans were compared by evaluating conformity numbers (CN) with 100% and 95% of prescription reference doses and heterogeneity indices (HI) for planning target volumes (PTVs) and maximum, mean, and dose-volume histogram (DVH) values for OARs. Results All 60Co IMRT plans achieved PTV coverage and OAR sparing that were similar to linac plans. PTV conformity for 60Co was within <1% and 3% of linac plans for 100% and 95% prescription reference isodoses, respectively, and heterogeneity was on average 4% greater. Comparisons of OAR mean dose showed generally better sparing with linac plans in the low-dose range <20 Gy, but comparable sparing for organs with mean doses >20 Gy. The mean doses for all 60Co plan OARs were within clinical tolerances. Conclusions A commercial 60Co MR-IGRT device can produce highly conformal IMRT treatment plans similar in quality to linac IMRT for a variety of disease sites. Additional work is in progress to evaluate the clinical benefit of other novel features of this MR-IGRT system.
UR - http://www.scopus.com/inward/record.url?scp=84931395127&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2015.02.057
DO - 10.1016/j.ijrobp.2015.02.057
M3 - Article
C2 - 26104932
AN - SCOPUS:84931395127
SN - 0360-3016
VL - 92
SP - 771
EP - 778
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 4
ER -